FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $241.2 million versus the consensus estimate of $241.11 million.
GUIDANCE:
Integra LifeSciences sees FY2016 EPS of $3.35-$3.50, versus the consensus of $3.43.... More

